| Tocilizumab |
EU/1/08/492/009 |
RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens |
Roche Registration GmbH, Германия |
Roche Pharma AG, Germany |
1441.74 |
288.35 |
1730.09 |
4% |
10 |
1451.74 |
290.35 |
1742.09 |
16% |
25 |
1476.74 |
295.35 |
1772.09 |
|
НСР-16864/28.09.2018; НСР-20222/22.11.2019 Предварително изпълнение; НСР-21748/25.06.2020 |
10.07.2020 |
02.08.2020 |
Активен |
16292 |
| Tocilizumab |
EU/1/08/4 92/009 |
RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens |
Roche Registration GmbH, Германия |
Roche Pharma AG, Germany |
1563.84 |
312.77 |
1876.61 |
4% |
10 |
1573.84 |
314.77 |
1888.61 |
16% |
25 |
1598.84 |
319.77 |
1918.61 |
|
НСР-16864/28.09.2018; НСР-20222/22.11.2019 Предварително изпълнение |
22.11.2019 |
02.01.2020 |
Неактивен |
16292 |
| Tocilizumab |
EU/1/08/4 92/009 |
RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens |
Roche Registration GmbH, Германия |
Roche Pharma AG, Germany |
1563.84 |
312.77 |
1876.61 |
4% |
10 |
1573.84 |
314.77 |
1888.61 |
16% |
25 |
1598.84 |
319.77 |
1918.61 |
|
НСР-16864/28.09.2018; НСР-20222/22.11.2019 Предварително изпълнение* |
22.11.2019 |
02.12.2019 |
Неактивен |
16292 |
| Tocilizumab |
EU/1/08/4 92/009 |
RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens |
Roche Registration GmbH, Германия |
Roche Pharma AG, Germany |
1647.81 |
329.56 |
1977.37 |
4% |
10 |
1657.81 |
331.56 |
1989.37 |
16% |
25 |
1682.81 |
336.56 |
2019.37 |
|
НСР-16864/28.09.2018 |
13.10.2018 |
02.11.2018 |
Неактивен |
16292 |
| Tocilizumab |
EU/1/08/4 92/009 |
RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens |
Roche Registration GmbH, Германия |
Roche Pharma AG, Germany |
1647.81 |
329.56 |
1977.37 |
4% |
10 |
1657.81 |
331.56 |
1989.37 |
16% |
25 |
1682.81 |
336.56 |
2019.37 |
|
НСР-16864/28.09.2018 |
13.10.2018 |
02.11.2018 |
Неактивен |
16292 |
| Tocilizumab |
EU/1/08/492/005 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 |
Roche Registration GmbH, Германия |
Roche Pharma AG Germany |
1016.78 |
203.36 |
1220.14 |
4% |
10 |
1026.78 |
205.36 |
1232.14 |
16% |
25 |
1051.78 |
210.36 |
1262.14 |
Промяна на обстоятелствата НСР-15986/22.06.2018. |
НСР-5078/21.11.2014; НСР-10019/18.08.2016; НСР-14455/17.11.2017; НСР-22048/31.07.2020 |
15.08.2020 |
02.09.2020 |
Активен |
3378 |
| Tocilizumab |
EU/1/08/492/005 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 |
Roche Registration GmbH, Германия |
Roche Pharma AG Germany |
1029.82 |
205.96 |
1235.78 |
4% |
10 |
1039.82 |
207.96 |
1247.78 |
16% |
25 |
1064.82 |
212.96 |
1277.78 |
Промяна на обстоятелствата НСР-15986/22.06.2018. |
НСР-5078/21.11.2014; НСР-10019/18.08.2016; НСР-14455/17.11.2017 |
02.12.2017 |
02.08.2018 |
Неактивен |
3378 |
| Tocilizumab |
EU/1/08/492/003 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 |
Roche Registration GmbH, Германия |
Roche Pharma AG Germany |
514.91 |
102.98 |
617.89 |
4% |
10 |
524.91 |
104.98 |
629.89 |
16% |
25 |
549.91 |
109.98 |
659.89 |
Промяна на обстоятелствата НСР-15987/22.06.2018. |
НСР-5077/21.11.2014; НСР-13342/28.07.2017 |
12.08.2017 |
02.08.2018 |
Активен |
3377 |
| Tocilizumab |
EU/1/08/492/003 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 |
Roche Registration GmbH, Германия |
Roche Pharma AG Germany |
514.91 |
102.98 |
617.89 |
4% |
10 |
524.91 |
104.98 |
629.89 |
16% |
25 |
549.91 |
109.98 |
659.89 |
Промяна на обстоятелствата НСР-15987/22.06.2018. |
НСР-5077/21.11.2014; НСР-13342/28.07.2017 |
12.08.2017 |
02.08.2018 |
Неактивен |
3377 |
| Tocilizumab |
EU/1/08/492/005 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 |
Roche Registration GmbH, Германия |
Roche Pharma AG Germany |
1029.82 |
205.96 |
1235.78 |
4% |
10 |
1039.82 |
207.96 |
1247.78 |
16% |
25 |
1064.82 |
212.96 |
1277.78 |
Промяна на обстоятелствата НСР-15986/22.06.2018. |
НСР-5078/21.11.2014; НСР-10019/18.08.2016; НСР-14455/17.11.2017 |
02.12.2017 |
02.08.2018 |
Неактивен |
3378 |
| Tocilizumab |
EU/1/08/492/001 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 |
Roche Registration GmbH, Германия |
Roche Pharma AG Germany |
205.97 |
41.19 |
247.16 |
4% |
8.24 |
214.21 |
42.84 |
257.05 |
16% |
25 |
239.21 |
47.84 |
287.05 |
Промяна на обстоятелствата НСР-15983/22.06.2018. |
НСР-5076/21.11.2014; НСР-10018/18.08.2016; НСР-14456/17.11.2017 |
02.12.2017 |
02.08.2018 |
Активен |
3376 |
| Tocilizumab |
EU/1/08/492/001 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 |
Roche Registration GmbH, Германия |
Roche Pharma AG Germany |
205.97 |
41.19 |
247.16 |
4% |
8.24 |
214.21 |
42.84 |
257.05 |
16% |
25 |
239.21 |
47.84 |
287.05 |
Промяна на обстоятелствата НСР-15983/22.06.2018. |
НСР-5076/21.11.2014; НСР-10018/18.08.2016; НСР-14456/17.11.2017 |
02.12.2017 |
02.08.2018 |
Неактивен |
3376 |
| Tocilizumab |
EU/1/08/492/001 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
205.97 |
41.19 |
247.16 |
4% |
8.24 |
214.21 |
42.84 |
257.05 |
16% |
25 |
239.21 |
47.84 |
287.05 |
|
НСР-5076/21.11.2014; НСР-10018/18.08.2016; НСР-14456/17.11.2017 |
02.12.2017 |
02.01.2018 |
Неактивен |
3376 |
| Tocilizumab |
EU/1/08/492/005 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
1029.82 |
205.96 |
1235.78 |
4% |
10 |
1039.82 |
207.96 |
1247.78 |
16% |
25 |
1064.82 |
212.96 |
1277.78 |
|
НСР-5078/21.11.2014; НСР-10019/18.08.2016; НСР-14455/17.11.2017 |
02.12.2017 |
02.01.2018 |
Неактивен |
3378 |
| Tocilizumab |
EU/1/08/492/003 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
514.91 |
102.98 |
617.89 |
4% |
10 |
524.91 |
104.98 |
629.89 |
16% |
25 |
549.91 |
109.98 |
659.89 |
|
НСР-5077/21.11.2014; НСР-13342/28.07.2017 |
12.08.2017 |
02.09.2017 |
Неактивен |
3377 |
| Tocilizumab |
EU/1/08/492/001 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
234.13 |
46.83 |
280.96 |
4% |
9.37 |
243.5 |
48.7 |
292.2 |
16% |
25 |
268.5 |
53.7 |
322.2 |
|
НСР-5076/21.11.2014; НСР-10018/18.08.2016 |
03.09.2016 |
02.10.2016 |
Неактивен |
3376 |
| Tocilizumab |
EU/1/08/492/005 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
1146.76 |
229.35 |
1376.11 |
4% |
10 |
1156.76 |
231.35 |
1388.11 |
16% |
25 |
1181.76 |
236.35 |
1418.11 |
|
НСР-5078/21.11.2014; НСР-10019/18.08.2016 |
03.09.2016 |
02.10.2016 |
Неактивен |
3378 |
| Tocilizumab |
EU/1/08/492/003 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
583.82 |
116.76 |
700.58 |
4% |
10 |
593.82 |
118.76 |
712.58 |
16% |
25 |
618.82 |
123.76 |
742.58 |
|
НСР-5077/21.11.2014 |
08.12.2014 |
08.12.2014 |
Неактивен |
3377 |
| Tocilizumab |
EU/1/08/492/001 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
234.6 |
46.92 |
281.52 |
4% |
9.38 |
243.98 |
48.8 |
292.78 |
16% |
25 |
268.98 |
53.8 |
322.78 |
|
НСР-5076/21.11.2014 |
08.12.2014 |
08.12.2014 |
Неактивен |
3376 |
| Tocilizumab |
EU/1/08/492/005 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
1151.79 |
230.36 |
1382.15 |
4% |
10 |
1161.79 |
232.36 |
1394.15 |
16% |
25 |
1186.79 |
237.36 |
1424.15 |
|
НСР-5078/21.11.2014 |
08.12.2014 |
08.12.2014 |
Неактивен |
3378 |
| Tocilizumab |
EU/1/08/492/005 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
1179.27 |
235.85 |
1415.12 |
4% |
10 |
1189.27 |
237.85 |
1427.12 |
16% |
25 |
1214.27 |
242.85 |
1457.12 |
|
НСР-2939/07.03.2014 |
25.03.2014 |
25.03.2014 |
Неактивен |
3378 |
| Tocilizumab |
EU/1/08/492/001 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
241.27 |
48.25 |
289.52 |
4% |
9.65 |
250.92 |
50.18 |
301.1 |
16% |
25 |
275.92 |
55.18 |
331.1 |
|
НСР-2941/07.03.2014 |
25.03.2014 |
25.03.2014 |
Неактивен |
3376 |
| Tocilizumab |
EU/1/08/492/003 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
598.62 |
119.72 |
718.34 |
4% |
10 |
608.62 |
121.72 |
730.34 |
16% |
25 |
633.62 |
126.72 |
760.34 |
|
НСР-2940/07.03.2014 |
25.03.2014 |
25.03.2014 |
Неактивен |
3377 |
| Tocilizumab |
EU/1/08/492/005 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
1203.5 |
240.7 |
1444.2 |
4% |
10 |
1213.5 |
242.7 |
1456.2 |
16% |
25 |
1238.5 |
247.7 |
1486.2 |
|
НСР-434/09.07.2013 |
30.07.2013 |
30.07.2013 |
Неактивен |
3378 |
| Tocilizumab |
EU/1/08/492/001 |
RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 |
Roche Registration Limited, Обединено Кралство |
Roche Pharma AG Germany |
242.8 |
48.56 |
291.36 |
4% |
9.71 |
252.51 |
50.5 |
303.01 |
16% |
25 |
277.51 |
55.5 |
333.01 |
|
НСР-436/09.07.2013 |
30.07.2013 |
30.07.2013 |
Неактивен |
3376 |